Shares Held (Direct Ownership) 1.4K
0% 3M change
0% 12M change
Total Value Held N/A

Christopher Cabell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2020
SELL
Payment of exercise price or tax liability
$71,984 $65.5 p/Share
1,099 Reduced 43.96%
1,401 Common Stock
Nov 25 2020
BUY
Exercise of conversion of derivative security
-
2,500 Added 50.0%
2,500 Common Stock

Also insider at

PULM
Pulmatrix, Inc. Healthcare
JATT-WT
JATT Acquisition Corp
CC

Christopher Cabell

EVP, Head of R&D, and CMO
San Diego, CA

Track Institutional and Insider Activities on ARNA

Follow ARENA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARNA shares.

Notify only if

Insider Trading

Get notified when an Arena Pharmaceuticals Inc insider buys or sells ARNA shares.

Notify only if

News

Receive news related to ARENA PHARMACEUTICALS INC

Track Activities on ARNA